AzTrials
AzTrials

Healthy SubjectsPI19/00507NCT05600192

Target Mitochondrial Fitness, Chronobiology and Metabolism

A study testing Aerobic or anaerobic exercise in people with Healthy Subjects, run by Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Exercise could be an element that affects the biochemical, metabolic and microbiome parameters of organisms. Thus, to identify and validate the effects of aerobic and anaerobic exercises at different times of the day (morning or afternoon) on mitochondrial fitness and whether this changes could have a relation with… Read more about this study

Who is it for?
Ages 20 to 55 yearsHealthy volunteers can take part
Conditions the study is for
Healthy Subjects
What is being tested?
Aerobic or anaerobic exercise
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
1 siteSpain
Study dates
18 Oct 2021to 31 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 55 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 20-
  • IMC <30 kg/m2
  • Informed consent

Who cannot join

  • Smoker
  • Previous physical exercise of more than 20 minutes / 2 times a week

Trial locations and contacts

1 site in 1 country.

Spain1 site
  • Hospital Universitario Virgen de la Victoria

    Málaga, 29010

Other trials in Spain

About this study

Exercise could be an element that affects the biochemical, metabolic and microbiome parameters of organisms. Thus, to identify and validate the effects of aerobic and anaerobic exercises at different times of the day (morning or afternoon) on mitochondrial fitness and whether this changes could have a relation with metabolism and cardiovascular parameters and microbiome is of great interest for its applicability in biomedicine.

As specific objectives of this project will study:

  1. - To study the direct effect of aerobic and anaerobic exercise at different time points in the day on mitochondria fitness (short study: basal, at the end of the exercise and 2 h after exercise).
  2. - To study mitochondria fitness under morning or afternoon aerobic and anaerobic exercise (prospective study: basal, 4, 8 and 12 weeks of the study).
  3. - To identify and validate modulators and target proteins of mitochondria fitness affected by exercise (miRNA omic and proteomic analysis of mitochondria from the different groups of the study at basal and 12 weeks of the study).
  4. - To study the relationship of the mitochondrial response (Objectives 1 and 2) to the different combination of exercises and chronobiology with anthropometric-clinical, carbohydrate and lipid metabolic and cardiovascular changes.
  5. - To check the effect of morning or afternoon aerobic and anaerobic exercise on gut microbiota and its relation to mitochondria fitness, clinical and metabolic parameters (basal, 4, 8 and 12 weeks of the study).
Being tested
Aerobic or anaerobic exercise
Keywords
Mitochondrial fitness, Metabolism, Chronobiology

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Aerobic or anaerobic exerciseOther

    Aerobic or anaerobic exercise in the morning or in the afternoon

Study groups in NCT05600192
Study groupRoleWhat they receive
Exercise armExperimentalSubjects perfom aerobic or anaerobic exercise in the morning or in the afternoon
Receives: Other: Aerobic or anaerobic exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in weight

    Weight in kg

    Measured: From baseline to week 12

  2. BMI (body mass index) changes

    Measured by body composition analysis

    Measured: From baseline to week 12

  3. Change in waist circumference

    Circumference in cm

    Measured: From baseline to week 12

  4. Change in hip circumference

    Circumference in cm

    Measured: From baseline to week 12

  5. Changes in diastolic and systolic blood pressure

    To analyze the effect of exercise on blood pressure

    Measured: From baseline to week 12

  6. Changes in body composition

    To analyze the effect of exercise on anthropometric parameters measured by bioelectrical impedance analysis

    Measured: From baseline to week 12

  7. Change in glucose concentration

    Glucose in mg/dl

    Measured: From baseline to week 12

  8. Change in insulin concentration

    Insulin in mg/dl

    Measured: From baseline to week 12

  9. Change in glycated haemoglobin concentration

    Glycated haemoglobin in mg/dl

    Measured: From baseline to week 12

  10. Change in Triglycerides concentration

    Triglycerides in mg/dl

    Measured: From baseline to week 12

  11. Change in cholesterol concentration

    Serum cholesterol in mg/dl

    Measured: From baseline to week 12

  12. Change in HDL concentration

    Serum HDL in mg/dl

    Measured: From baseline to week 12

  13. Change in LDL concentration

    Serum LDL in mg/dl

    Measured: From baseline to week 12

  14. Change in transaminases concentration

    Serum transaminases in UI/l

    Measured: From baseline to week 12

  15. Change in creatinine concentration

    Creatinine in mg/dl

    Measured: From baseline to week 12

  16. Change in uric acid concentration

    Uric acid in mg/dl

    Measured: From baseline to week 12

  17. Change in alkaline phosphatase concentration

    Serum alkaline phosphatase in UI/l

    Measured: From baseline to week 12

  18. Change in bilirubin concentration

    Serum bilirubin in mg/dl

    Measured: From baseline to week 12

  19. Change in lactate concentration

    Serum lactate in mmol/L

    Measured: From baseline to week 12

  20. Change in cortisol concentration

    Serum cortisol in nmol/L

    Measured: From baseline to week 12

  21. Change in total and free testosterone concentration

    Serum total and free testosterone in nmol/L

    Measured: From baseline to week 12

  22. Change in melatonine concentration

    Serum melatonine in pg/ml

    Measured: From baseline to week 12

  23. Characterize exercise participant behavior

    International Physical Activity Questionnaire (IPAQ). The IPAQ consists of 7 questions about the frequency, duration and intensity of activity (moderate and intense) carried out in the last seven days, as well as walking and sitting time in a work day. It evaluates three characteristics of physics (PA): intensity (mild, moderate or vigorous), frequency (days per week) and duration (time per day). Weekly activity is recorded in Mets (Metabolic Equivalent of Task or Metabolic Index Units) per minute and week.

    Measured: From baseline to week 12

  24. Mediterranean diet adherence questionnaire

    To evaluate adherence to a Mediterranean diet pattern. It consists of 14 items in which different components of the Mediterranean diet are evaluated (number of pieces of fruit consumed per day, number of portions of legumes consumed per week...). Each item is scored as 0 or 1. A total score of <9 indicates poor adherence, while a score of ≥9 indicates good adherence.

    Measured: From baseline to week 12

  25. Change in faecal microbiota

    To evaluate faecal microbiota composition in the studied subjects and the effect of aerobic and anaerobic exercise in the morning or afternoon on faecal microbiota composition. 16S rRNA amplicons of fecal community DNA

    Measured: From baseline to week 12

  26. Change in fitness mitochondrial

    To evaluate the effect of aerobic and anaerobic exercise in the morning or afternoon on mitochondrial fitness, evaluated by mitochondrial gene expression and protein abundance, mitochondrial metabolites, mitochondrial markers trough flow citometry.

    Measured: From baseline to week 12

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Oct 2022
  2. Study start18 Oct 2021
  3. Primary completion29 Jul 2022
  4. Study completion31 Dec 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05600192
Sponsor's protocol ID
PI19/00507
Acronym
PI19/00507
Status last verified
Sep 2022
First submitted
26 Oct 2022
Last updated
2 Nov 2022
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Aerobic or anaerobic exercise in people with Healthy Subjects, run by Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 2 Nov 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in weight (time frame: From baseline to week 12). The study lists 26 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2022.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in